Perceptive and subjective evaluation of speech disorders in Parkinson's disease.


Journal

Journal of biological regulators and homeostatic agents
ISSN: 0393-974X
Titre abrégé: J Biol Regul Homeost Agents
Pays: Italy
ID NLM: 8809253

Informations de publication

Date de publication:
Historique:
entrez: 2 6 2020
pubmed: 2 6 2020
medline: 25 8 2020
Statut: ppublish

Résumé

Parkinson's disease (PD), which is not only a motor disease, is one of the most frequent neurodegenerative diseases and affects 1.5-2% of people worldwide. The role of its non motor-symptoms is of first importance on quality of life. Speech impairment is considered a part of motor impairment and is widespread in PD where most frequent speech impairment is Hypokinetic dysarthria, a disorder characterized by reduced articulation movements and phonetic monotony. Many PD patients show difficulty in accessing the lexicon related to cognitive impairment. Clinical evaluation of speech disorders in PD includes the clinical history, verbal and non-verbal assessment of the voice, evaluation of the calibre of the language. It is also important to self-assess speech disturbances because PD patients often do not realize their own deficits. Self-assessment tests comprise subjective assessment of communicative disorder in different social situations, description of adopted strategies, perception of the reactions of interlocutors. The comparison between perceptive and subjective examination of speech disorders in PD patients are described in order to evaluate the presence of these deficits and their impact on quality of life in order to initiate early treatment with specific speech therapy.

Identifiants

pubmed: 32475102
doi: 10.23812/19-412-L-2
pii: 37
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

683-686

Informations de copyright

Copyright 2020 Biolife Sas. www.biolifesas.org.

Auteurs

D Melchionda (D)

Neurology Department, University Hospital of Foggia, Foggia, Italy.

G Varvara (G)

Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy.

D Perfetto (D)

Regional Health District of Molise (ASReM), Campobasso, Italy.

B Mascolo (B)

Neurology Department, University Hospital of Foggia, Foggia, Italy.

C Avolio (C)

Neurology Department, University Hospital of Foggia, Foggia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH